Xiaochao Ma, PhDProfessor, Pharmaceutical Sciences
Dr. Ma is a Professor in the Department of Pharmaceutical Sciences and a member of the Center for Pharmacogenetics, University of Pittsburgh School of Pharmacy. He obtained his Ph.D. in Pharmacology and Toxicology from Shanghai Institute of Materia Medica, Chinese Academy of Sciences in 2003. From there, he went to National Institutes of Health (NIH) and completed his postdoctoral training in Dr. Frank J. Gonzalez’s laboratory in 2008. Afterward, he worked as an Assistant Professor at University of Kansas Medical Center, until he joined the University of Pittsburgh in 2013.
Dr. Ma’s research interests include drug metabolism, drug-induced liver injury, toxicometabolomics, and safety-based precision medicine.
• 2007 Fellows Award for Research Excellence, sponsored by NIH
• 2007 Postdoctoral Scientist Award in Toxicology (1st place), sponsored by the American Society for Pharmacology and Experimental Therapeutics (ASPET)
• 2008 Fellows Award for Research Excellence, sponsored by NIH
• 2018 The ASPET 2018 Junior Investigator Award, sponsored by the Toxicology Division, ASPET.
R01DK126875, NIDDK/NIH, 2021-2026. The ABCG2 transporter in protoporphyrin IX disposition: from toxicity to therapy. PI: Xiaochao Ma
R01AI131983, NIAID/NIH, 2017-2022. Pharmacoenhancers for antiretroviral therapy: safety and future development. PI: Xiaochao Ma
R21AT011088, NCCIH/NIH, 2020-2022. Preclinical screening and validation for PXR-mediated herb-drug interactions associated with anti-HIV therapy. PI: Xiaochao Ma